Indazole-Phenol Bioisosterism in NMDA GluN2B Receptor Antagonists with Metabolic Advantage

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2023; 19(11): 1156
DOI: 10.1055/s-0042-1751600

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Nicholas A. Meanwell (The Baruch S. Blumberg Institute and University of Michigan)

NMDA GluN2B antagonist - indazole - phenol bioisostere - resistance to glucuronidation

Article published online:
14 October 2023

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany